ALGOCYTE
LIVE

Serial Number

79327802

Owner

Oxford Immune Algorithmics Ltd

Attorney

Cheryl L. Burbach

Filing Date

Sep 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ALGOCYTE Trademark

Serial Number: 79327802 • Registration: 7039106

ALGOCYTE is a trademark filed by Oxford Immune Algorithmics Ltd on September 17, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Oxford Immune Algorithmics Ltd (3 trademarks)

Davidson House,

Entity Type: 99

Trademark Details

Filing Date

September 17, 2021

Registration Date

May 2, 2023

Published for Opposition

February 14, 2023

Goods & Services

Apparatus for blood analysis; apparatus for blood monitoring for medical use; apparatus for blood tests for medical use; apparatus for determining blood flow; apparatus for taking blood; apparatus for taking blood samples; autologous blood processing instruments, namely, syringes, needles and tourniquets; automated blood collection apparatus; automated blood collection instruments; automated blood separation apparatus; automated blood separation instruments; blood collection needles; blood collection tubes for medical use; blood filters

Computer software, recorded, for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable software and applications for mobile devices for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable computer software applications for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable computer software converters of natural language into machine executable commands; downloadable software development programmes; downloadable computer software development tools; downloadable software for computers for monitoring the human immune system to detect, prevent, and treat human diseases; downloadable software for online messaging; downloadable software for operating and managing integrated circuit components; downloadable software for optical character recognition; downloadable software for processing digital images; downloadable software for processing images, graphics and text; downloadable software for processing images, graphics, audio, video and text; downloadable application software for cloud computing services; downloadable artificial intelligence software for analysis of blood and cells in humans; downloadable artificial intelligence software for healthcare for testing analysis of blood and cells in humans; downloadable authentication software for patient blood and cell testing and analysis; downloadable bioinformatics software for patient blood and cell testing and analysis; downloadable biometric software for patient blood and cell testing and analysis; downloadable computer interface software for patient blood and cell testing and analysis; downloadable computer programming software for patient blood and cell testing and analysis; downloadable computer programs for patient blood and cell testing and analysis; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; digital optical transmission apparatus; downloadable optical barcode recognition (OBR) software; downloadable optical character recognition (OCR) software; downloadable optical mark recognition (OMR) software; optical character recognition apparatus (OCR)

Services for the medical testing of blood; medical analysis for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical analysis services relating to the treatment of persons provided by a medical laboratory; analysis of human serum for medical treatment; analysis of human tissues for medical treatment

Software as a service (SaaS) featuring computer software platforms for artificial intelligence; software as a service (SaaS) featuring software for deep learning; software as a service (SaaS) featuring software for deep neural networks; software as a service (SaaS) featuring software for machine learning; software as a service (SaaS) featuring software platforms for graphic design; software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks; computer software consultancy services; advisory services in the field of product development and quality improvement of software; advisory services relating to computer software design; advisory services relating to man-machine interfaces for computer software, namely, to the design and development of computers; advisory services relating to the rental of computers or computer software; advisory services relating to the use of computer software; software engineering; software engineering services; computer software installation; computer software maintenance services; research of computer software; computer software consultancy; computer software consultancy services; computer software consultation; computer software consulting; computer software development; computer software engineering; blood analysis services; blood analysis services for scientific research purposes; analysis of human serum for medical research

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 16, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 16, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 16, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 16, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 16, 2026 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 28, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2023 FICS
FINAL DISPOSITION PROCESSED
Aug 7, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 2, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 2, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 14, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 25, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 25, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 9, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2022 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 30, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 29, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 17, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 9, 2021 REPR